Novo Nordisk A/S (NVO)

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Q: What's the best way to play the GLP-1/Semaglutide bandwagon now that the WHO is encouraging its use as a way to better health through weight loss?

Read Answer Asked by John on December 03, 2025

Q: Has NVO fallen to a level you see as attractive?

Read Answer Asked by Kim on November 24, 2025

Salesforce Inc. (CRM $260.57)
- $260.57 P/E (TTM): 34.7X Cap: $244.15B
- View CRM Profile
- View Questions on CRM
UnitedHealth Group Incorporated (DE) (UNH $330.91)
- $330.91 P/E (TTM): 17.72X Cap: $302.08B
- View UNH Profile
- View Questions on UNH
Novo Nordisk A/S (NVO $47.86)
- $47.86 P/E (TTM): 13.55X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
The Trade Desk Inc. (TTD $40.05)
- $40.05 P/E (TTM): 45.23X Cap: $19.36B
- View TTD Profile
- View Questions on TTD
Crocs Inc. (CROX $89.70)
- $89.70 P/E (TTM): 28.74X Cap: $4.65B
- View CROX Profile
- View Questions on CROX
Axon Enterprise Inc. (AXON $550.95)
- $550.95 P/E (TTM): 172.34X Cap: $43.44B
- View AXON Profile
- View Questions on AXON
e.l.f. Beauty Inc. (ELF $81.40)
- $81.40 P/E (TTM): 56.6X Cap: $4.86B
- View ELF Profile
- View Questions on ELF
Duolingo Inc. (DUOL $199.75)
- $199.75 P/E (TTM): 23.49X Cap: $8.56B
- View DUOL Profile
- View Questions on DUOL

Q: What would be your US stocks for tax loss selling?
Thank you so much. Lorraine

Read Answer Asked by Lorraine on November 24, 2025